Back

12
Cardiac amyloid in TAVI Patients - bystander or disease modifier?

European Heart Journal - Cardiovascular Imaging

8 June 2019
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Webinar
Cardiac amyloidosis in valvular heart disease
29 September 2021
thumbnail
Congress Presentation
Burden of transthyretin amyloid cardiomyopathy in treatment-naive patients by heart failure severity: results from a large, non-interventional, real-world study
21 May 2023
thumbnail
Congress Presentation
First degree atrioventricular block as an early predictor of advanced conduction system disease in Val 142Ile hereditary cardiac amiloydosis.
27 August 2022
thumbnail
Congress Presentation
Prevalence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources